<VariationArchive RecordType="classified" VariationID="190152" VariationName="NM_000124.3(ERCC6):c.1684_1705del" VariationType="Deletion" Accession="VCV000190152" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-03" DateCreated="2015-05-09" MostRecentSubmission="2015-05-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="188042" VariationID="190152">
      <GeneList>
        <Gene Symbol="ERCC6" FullName="ERCC excision repair 6, chromatin remodeling factor" GeneID="2074" HGNC_ID="HGNC:3438" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>10q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49434881" stop="49539538" display_start="49434881" display_stop="49539538" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50664490" stop="50747146" display_start="50664490" display_stop="50747146" Strand="-" />
          </Location>
          <OMIM>609413</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000124.3(ERCC6):c.1684_1705del</Name>
      <VariantType>Deletion</VariantType>
      <XRefList>
        <XRef ID="CA274693" DB="ClinGen" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The submitter defined the allele only on the NM_000124.3.  This location crosses an exon boundary, and the genomic basis of this deletion was not reported.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000124.3(ERCC6):c.1684_1705del AND Cockayne syndrome type 2" Accession="RCV000170370" Version="1">
        <ClassifiedConditionList TraitSetID="433">
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2011-06-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-06-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-05-09" MostRecentSubmission="2015-05-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="433" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="405021" SubmissionDate="2015-04-13" DateLastUpdated="2015-05-09" DateCreated="2015-05-09">
        <ClinVarSubmissionID localKey="NM_000124.3:c.1684_1705del|OMIM:133540" />
        <ClinVarAccession Accession="SCV000222785" DateUpdated="2015-05-09" DateCreated="2015-05-09" Type="SCV" Version="1" SubmitterName="Claritas Genomics" OrgID="1179" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-06-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2007</Attribute>
          <Citation>
            <ID Source="PubMed">18414213</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.3:c.1684_1705del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cockayne syndrome, type B</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="133540" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="405021" TraitType="Disease" MappingType="Name" MappingValue="Cockayne syndrome, type B" MappingRef="Preferred">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

